Connecticut 2025 2025 Regular Session

Connecticut Senate Bill SB01191 Introduced / Fiscal Note

Filed 02/25/2025

                    OFFICE OF FISCAL ANALYSIS 
Legislative Office Building, Room 5200 
Hartford, CT 06106  (860) 240-0200 
http://www.cga.ct.gov/ofa 
SB-1191 
AN ACT ESTABLISHING A PANCREATIC CANCER SCREENING 
AND TREATMENT REFERRAL PROGRAM.  
 
Primary Analyst: NB 	2/24/25 
Contributing Analyst(s):    
Reviewer: JS 
 
 
 
OFA Fiscal Note 
 
State Impact: 
Agency Affected Fund-Effect FY 26 $ FY 27 $ 
Public Health, Dept. GF - Cost 477,996 498,161 
State Comptroller - Fringe 
Benefits
1
 
GF - Cost 25,064 33,419 
Note: GF=General Fund 
  
Municipal Impact: None  
Explanation 
The bill requires the Department of Public Health (DPH) to establish 
a pancreatic cancer screening and treatment referral program, resulting 
in a cost to DPH of $477,996 in FY 26 and $498,161 in FY 27 (and annually 
thereafter) and a cost to the Office of State Comptroller – Fringe Benefits 
of $25,064 in FY 26 and $33,419 in FY 27. It is anticipated that DPH will 
start the program as soon as possible in FY 26, ahead of the bill's 
deadline of January 1, 2026. 
The costs to DPH include one new Health Program Associate (HPA) 
2 position with a salary of $61,568 in FY 26 and $82,091 in FY 27, and 
annually thereafter. Fringe benefits for this position are $25,064 in FY 26 
and $33,419 in FY 27 to the Office of State Comptroller – Fringe Benefits. 
The FY 26 HPA salary and fringe benefits are adjusted to reflect a three-
                                                
1
The fringe benefit costs for most state employees are budgeted centrally in accounts 
administered by the Comptroller. The estimated active employee fringe benefit cost 
associated with most personnel changes is 40.71% of payroll in FY 26.  2025SB-01191-R000007-FN.DOCX 	Page 2 of 2 
 
 
quarter year's pay, anticipating a start date of October 1
st
, 2025. The HPA 
will be responsible for coordinating pancreatic cancer outreach, 
education, screening, quality assurance compliance, and data collection. 
Additional costs to DPH are anticipated to include ongoing other 
annual expenses totaling $416,428 in FY 26
2
 (with a one-time laptop 
equipment cost of $4,000), and $416,070 in FY 27 continuing into the out 
years, for: (1) an electronic data entry system ($59,000) for 21 hospitals 
in five different health systems to access, (2) additional staff time for 
Community Health Navigators in each of the five health systems 
($62,400 each for a total of $312,000) responsible for entering patient 
screening data, (3) a community outreach program ($30,500) to educate 
the public, (4) mileage reimbursement ($9,700) for HPA monthly 
hospital visits, (5) standard fleet costs ($4,620), and (6) general office 
supplies ($250). 
These costs are similar to those for an existing DPH lung cancer 
screening program. 
The Out Years 
The annualized ongoing fiscal impact identified above would 
continue into the future subject to inflation.  
                                                
2
 Other expense items such as mileage reimbursement, fleet costs, and general office 
supplies are reduced in FY 26 to reflect a three-quarter year need, also anticipating 
HPA start date of October 1, 2025.